Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

as prior studies have reported GLP-1 receptor agonist discontinuation rates of up to 81%, Emanuel's group wrote. They added that the links between weight loss and discontinuation and between ...

A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...

Among patients with diabetes, the use of GLP-1 RAs compared with standard care is associated with a reduced risk for neurocognitive and cardiometabolic disorders, and with an increased risk for ...

(AP Video: Laura Bargfeld) A woman holds up a dosage of Wegovy, a drug used for weight loss ... For adults, about half think it’s a good thing, and about 2 in 10 think it’s a bad thing. The popular ...